Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1182/blood-2020-139948
其他信息:
出版社: American Society of Hematology
作者: Christina U Lorentz; Norah G Verbout; Joseph J Shatzel; Michael Wallisch; Brandon D Markway; Monica T Hinds; Owen J T McCarty; David Gailani; Jeffrey I. Weitz; Erik I Tucker; András Gruber
全文下载地址: https://ashpublications.org/blood/article/136/Supplement%201/23/469854/Safety-and-Efficacy-of-the-Contact-Activation

